DONISI, CLELIA
 Distribuzione geografica
Continente #
EU - Europa 9.294
NA - Nord America 435
AS - Asia 111
AF - Africa 3
OC - Oceania 2
Totale 9.845
Nazione #
IT - Italia 9.130
US - Stati Uniti d'America 426
SE - Svezia 84
CN - Cina 43
IN - India 20
NL - Olanda 18
KR - Corea 16
FI - Finlandia 13
GB - Regno Unito 13
SG - Singapore 9
CA - Canada 8
FR - Francia 8
DE - Germania 7
BE - Belgio 6
HK - Hong Kong 5
IE - Irlanda 4
TH - Thailandia 4
VN - Vietnam 4
ES - Italia 3
GR - Grecia 3
IR - Iran 3
JP - Giappone 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
CH - Svizzera 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
SC - Seychelles 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 9.845
Città #
Cagliari 9.050
Nyköping 74
Chandler 66
Ashburn 47
Boardman 45
Fairfield 42
New York 30
Shanghai 24
Rome 21
Seattle 18
Houston 17
Seoul 16
Pune 15
Wilmington 14
San Diego 13
Woodbridge 13
Amsterdam 12
Boston 12
Cambridge 12
Helsinki 12
Toronto 7
Paris 6
Menlo Park 5
Dong Ket 4
Hefei 4
La Maddalena 4
London 4
Milan 4
Naples 4
Chicago 3
Islington 3
Los Angeles 3
Naaldwijk 3
Peristeri 3
San Francisco 3
Sassari 3
Turin 3
Brussels 2
Delhi 2
Don Mueang 2
Dublin 2
Enna 2
Godo 2
Hong Kong 2
Jacksonville 2
Kyjov 2
Leuven 2
Livorno 2
Molenbeek-Saint-Jean 2
Nakano 2
Nanjing 2
Pamplona 2
Romainville 2
Salerno 2
Sydney 2
Vienna 2
Washington 2
Xian 2
Alexandria 1
Amgaon 1
Ankara 1
Basel 1
Beijing 1
Bergamo 1
Bilbao 1
Cairo 1
Chandigarh 1
Ebisu 1
Exeter 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Hangzhou 1
Heidelberg 1
Hounslow 1
Lecce 1
Magelang 1
Miami Beach 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Quartu Sant'Elena 1
Rockville 1
Sambuca di Sicilia 1
San Mateo 1
Shenzhen 1
Singapore 1
Somerville 1
South Deerfield 1
Stockholm 1
Tabriz 1
Totale 9.695
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.118
New therapeutic targets in pancreatic cancer 1.306
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 607
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 510
Molecular-driven treatment for biliary tract cancer: the promising turning point 461
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 450
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 427
Uncovering key targets of success for immunotherapy in pancreatic cancer 413
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 348
Immune Checkpoint Inhibitors in the Treatment of HCC 339
BRCA-mutant pancreatic ductal adenocarcinoma 337
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 313
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 302
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 288
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 271
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 269
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 253
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 234
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 176
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 172
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 86
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 70
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 61
null 47
null 27
Immunotherapy and Cancer: The Multi-Omics Perspective 23
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 13
Totale 9.921
Categoria #
all - tutte 16.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 31 8 6 7 4 11
2020/20211.659 15 25 17 585 324 205 58 116 47 116 76 75
2021/20221.168 69 63 4 29 60 100 61 89 77 116 228 272
2022/20233.754 325 526 339 242 270 296 202 315 305 422 333 179
2023/20243.273 160 121 119 189 289 589 566 256 250 247 386 101
Totale 9.921